BASE life science A/S — Credit Rating and Financial Key Figures
Credit rating
Company information
About BASE life science A/S
BASE life science A/S (CVR number: 30906942K) is a company from KØBENHAVN. The company recorded a gross profit of 236.8 mDKK in 2023. The operating profit was -82.1 mDKK, while net earnings were -88.3 mDKK. The profitability of the company measured by Return on Assets (ROA) was -46.2 %, which can be considered poor and Return on Equity (ROE) was -99.8 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at -31.1 %. This indicates that the company's debt surpasses the value of its total assets, posing significant financial risk. BASE life science A/S's liquidity measured by quick ratio was 1.3 which is at a high level. Thus, the company is in a strong financial position, with liquid assets surpassing current liabilities. It is well-prepared to cover short-term financial obligations.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|
Volume | ||||
Net sales | ||||
Gross profit | 110 194.51 | 158 135.50 | 202 294.94 | 236 774.34 |
EBIT | 20 726.47 | 31 815.00 | -24 455.13 | -82 103.76 |
Net earnings | 17 277.05 | 24 195.00 | -31 224.29 | -88 307.13 |
Shareholders equity total | 28 914.10 | 50 215.00 | 21 496.23 | -66 598.61 |
Balance sheet total (assets) | 57 389.26 | 100 285.00 | 119 657.68 | 155 434.23 |
Net debt | -6 800.58 | - 100.17 | -10 627.35 | 87 216.35 |
Profitability | ||||
EBIT-% | ||||
ROA | 36.2 % | 40.5 % | -22.1 % | -46.2 % |
ROE | 59.8 % | 61.2 % | -87.1 % | -99.8 % |
ROI | 63.4 % | 72.8 % | -61.4 % | -120.7 % |
Economic value added (EVA) | 17 489.17 | 23 588.99 | -32 684.95 | -84 822.34 |
Solvency | ||||
Equity ratio | 50.6 % | 50.6 % | 18.3 % | -31.1 % |
Gearing | 8.8 % | 7.1 % | 7.5 % | -159.0 % |
Relative net indebtedness % | ||||
Liquidity | ||||
Quick ratio | 2.1 | 1.9 | 1.2 | 1.3 |
Current ratio | 2.1 | 1.9 | 1.1 | 1.2 |
Cash and cash equivalents | 9 347.61 | 3 676.31 | 12 229.01 | 18 681.48 |
Capital use efficiency | ||||
Trade debtors turnover (days) | ||||
Net working capital % | ||||
Credit risk | ||||
Credit rating | BBB | BBB | BBB | BB |
Variable visualization
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions

... and more!
No registration needed.